bioRxiv · 10.1101/2025.01.28.635342
Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage Derivatization
Abstract
Diversification of structurally complex natural products remains a key challenge in the discovery of next-generation therapeutics. Premarineosin A, a potent and selective antimalarial natural product, is a promising yet underexplored scaffold due to limited availability and synthetic complexity. In this work, we overcome both barriers by coupling metabolic engineering with late-stage derivatization, enabling the first systematic exploration of the premarineosin A scaffold. Rational engineering of Streptomyces eitanensis, encoding a (-)-premarineosin A biosynthetic gene cluster, increased titers over 200-fold. Sustainable production of (-)-premarineosin A enabled a unique semi-synthetic and biocatalytic derivatization campaign. In this first structure-activity relationship study of premarineosin A, we accessed a suite of novel analogs, including a C12-brominated derivative with nanomolar potency (EC50 < 5 nM). This work establishes (-)-premarineosin A as a tractable and evolvable antimalarial scaffold, demonstrating how chemical biology approaches can unlock new structural and pharmacological space from complex microbial metabolites.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
McBride, C. M., McCauley, M., Harris, N. R., Amin, S., Verhey-Henke, L., Teklemichael, A. A., Oliphant, E. N., Dranchak, P., Curtis, B. J., Lev, K. L., Qu, F., Snodgrass, H. M., Lewis, J. C., Inglese, J., Su, X.-z., Pereira, F., Sherman, D. H.. 2025-01-28. Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage Derivatization. https://doi.org/10.1101/2025.01.28.635342
Cite the original work for its findings. Save a collection to share your selection of sources.